Novavax, Inc (NASDAQ: NVAX) is -20.27% lower on its value in year-to-date trading and has touched a low of $3.81 and a high of $23.86 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NVAX stock was last observed hovering at around $5.86 in the last trading session, with the day’s gains setting it 0.55%.
Currently trading at $6.41, the stock is -5.46% and -14.72% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 6.1 million and changing 9.39% at the moment leaves the stock -36.72% off its SMA200. NVAX registered 49.07% gain for a year compared to 6-month loss of -50.33%. The firm has a 50-day simple moving average (SMA 50) of $7.5162 and a 200-day simple moving average (SMA200) of $10.1298.
The stock witnessed a -19.77% gain in the last 1 month and extending the period to 3 months gives it a -25.51%, and is -1.99% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 15.54% over the week and 8.65% over the month.
Novavax, Inc (NVAX) has around 952 employees, a market worth around $1.03B and $682.16M in sales. Fwd P/E is 16.37. Profit margin for the company is -27.49%. Distance from 52-week low is 68.24% and -73.13% from its 52-week high.
with sales reaching $204.07M over the same period.The EPS is expected to grow by 151.68% this year, but quarterly earnings will post -21.98% year-over-year. Quarterly sales are estimated to grow 117.44% in year-over-year returns.
Novavax, Inc (NVAX) Top Institutional Holders
306.0 institutions hold shares in Novavax, Inc (NVAX), with institutional investors hold 66.01% of the company’s shares. The shares outstanding are 160.42M, and float is at 146.57M with Short Float at 25.16%. Institutions hold 60.22% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 14.08 million shares valued at $178.19 million. The investor’s holdings represent 10.0599% of the NVAX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 11.85 million shares valued at $149.98 million to account for 7.984 of the shares outstanding. The other top investors are SHAH CAPITAL MANAGEMENT which holds 9.66 million shares representing 6.5118% and valued at over $122.32 million, while D. E. SHAW & CO., INC. holds 4.2608 of the shares totaling 6.32 million with a market value of $80.04 million.
Novavax, Inc (NVAX) Insider Activity
#####
Novavax, Inc disclosed in a document filed with the SEC on Dec 13 ’24 that King Rachel K. (Director) sold a total of 4,150 shares of the company’s common stock. The trade occurred on Dec 13 ’24 and was made at $9.02 per share for $37435.0. Following the transaction, the insider now directly holds 14770.0 shares of the NVAX stock.
Still, SEC filings show that on Dec 31 ’24, YOUNG JAMES F (Director) disposed off 5,400 shares at an average price of $8.00 for $43200.0. The insider now directly holds 51,760 shares of Novavax, Inc (NVAX).
